Orange (OTCMKTS:ORANY – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 213,206 shares traded hands during trading, an increase of 29% from the previous session’s volume of 164,989 shares.The stock last traded at $18.4340 and had previously closed at $18.11.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the company. Zacks Research raised Orange from a “strong sell” rating to a “hold” rating in a report on Monday, June 8th. The Goldman Sachs Group raised shares of Orange from a “hold” rating to a “buy” rating in a research note on Tuesday, May 5th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Orange in a research note on Thursday, June 18th. Kepler Capital Markets raised shares of Orange from a “hold” rating to a “strong-buy” rating in a report on Wednesday, July 8th. Finally, Citigroup reiterated a “buy” rating on shares of Orange in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Orange presently has a consensus rating of “Moderate Buy”.
View Our Latest Research Report on ORANY
Orange Price Performance
About Orange
Orange SA, commonly known as Orange, is a multinational telecommunications operator headquartered in Paris, France. The company has its roots in the former state-owned France Télécom and later consolidated its international operations under the Orange brand. Orange provides a wide range of connectivity and communications services and maintains a significant presence across Europe, and in many countries in Africa and the Middle East, serving both consumer and business customers.
Orange’s core activities include mobile and fixed-line telephony, broadband and fiber internet access, and television services for retail customers.
Recommended Stories
- Five stocks we like better than Orange
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
- Why Micron Is Doubling Down While the HBM Shortage Persists
- China’s Helium Ban Could Reshape the AI Supply Chain
Receive News & Ratings for Orange Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orange and related companies with MarketBeat.com's FREE daily email newsletter.
